The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2013-04-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2013.03.070PMID 23545258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug combination studies and their synergy quantification using the Chou-Talalay method--letter.

  2015cited by this paper
• Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway

  2013cited by this paper
• Human hepatocyte carcinogenesis

  2013cited by this paper
• Pathways and targets in hepatocellular carcinoma

  2012cited by this paper
• Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma

  2012cited by this paper
• Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells.

  2012cited by this paper
• Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal‐regulated kinase

  2012influential reference
• Targeting sphingosine kinase 1 in cancer.

  2012cited by this paper
• Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells.

  2012cited by this paper
• Advanced hepatocellular carcinoma . Review of targeted molecular drugs

  2011cited by this paper
• [Targeting the RAS signalling pathway in cancer].

  2011cited by this paper
• Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non–Small Cell Lung Cancer

  2011cited by this paper
• Advanced hepatocellular carcinoma. Review of targeted molecular drugs.

  2011cited by this paper
• Inhibition of SPHK1 suppresses phorbol 12-myristate 13-acetate-induced metastatic phenotype in colorectal cancer HT-29 cells.

  2011cited by this paper
• Ciblage de la voie de signalisation RAS pour le traitement des cancers

  2011cited by this paper
• Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells

  2011cited by this paper
• Regulation of sphingosine kinase and sphingolipid signaling.

  2011cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

  2010cited by this paper
• Regulation of cancer cell migration and invasion by sphingosine-1-phosphate.

  2010cited by this paper
• Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.

  2009influential reference
• Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cells.

  2009cited by this paper
• Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation*

  2009cited by this paper
• Role of focal adhesion kinase in human cancer: a potential target for drug discovery.

  2007cited by this paper
• Focal adhesions: paradigm for a signaling nexus.

  2006cited by this paper
• Focal adhesion kinase: in command and control of cell motility

  2005cited by this paper
• Cdc42–MRCK and Rho–ROCK signalling cooperate in myosin phosphorylation and cell invasion

  2005cited by this paper
• Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2.

  2004cited by this paper
• Activation of sphingosine kinase 1 by ERK1/2‐mediated phosphorylation

  2003cited by this paper
• Mechanics of cell spreading: role of myosin II

  2003cited by this paper
• Discovery and evaluation of inhibitors of human sphingosine kinase.

  2003cited by this paper
• An oncogenic role of sphingosine kinase.

  2000cited by this paper
• Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.

  1990cited by this paper
• Focal Adhesions Paradigm for a Signaling Nexus

  year unknowncited by this paper

• Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy

  2024cites this paper
• Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential

  2024cites this paper
• Integrative roles of sphingosine kinase in liver pathophysiology

  2023cites this paper
• Krüppel-like factor 12 regulates aging ovarian granulosa cell apoptosis by repressing SPHK1 transcription and sphingosine-1-phosphate (S1P) production

  2023cites this paper
• HBx downregulated decorin and decorin‐derived peptides inhibit the proliferation and tumorigenicity of hepatocellular carcinoma cells

  2023cites this paper
• Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer.

  2022cites this paper
• Targeting Sphingolipids for Cancer Therapy

  2021cites this paper
• Sphk1 promotes salivary adenoid cystic carcinoma progression via PI3K/Akt signaling.

  2021cites this paper
• Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy

  2021cites this paper
• Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma.

  2019cites this paper
• Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.

  2017cites this paper
• SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells

  2017cites this paper
• Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1‐phosphate signaling pathway in a mouse model of diethylnitrosamine‐induced hepatocellular carcinoma

  2017cites this paper
• SphK 1 is involved in the progression of human pancreatic cancer

  2017cites this paper
• Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells

  2016cites this paper
• Impact of PKM 2 gene silencing on biological behavior of HepG 2 cells

  2016cites this paper
• From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).

  2016cites this paper
• SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.

  2016cites this paper
• Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.

  2015cites this paper
• SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.

  2015cites this paper
• Sphingosine kinases signalling in carcinogenesis.

  2015cites this paper
• A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells.

  2015cites this paper
• Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

  2014cites this paper
• Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK.

  2014cites this paper
• Effects of Inhibition of Serine Palmitoyltransferase (SPT) and Sphingosine Kinase 1 (SphK1) on Palmitate Induced Insulin Resistance in L6 Myotubes

  2013cites this paper